12/15-Lipoxygenase Orchestrates the Clearance of Apoptotic Cells and Maintains Immunologic Tolerance  by Uderhardt, Stefan et al.
Immunity
Article12/15-Lipoxygenase Orchestrates the Clearance
ofApoptoticCellsandMaintainsImmunologicTolerance
Stefan Uderhardt,1,2 Martin Herrmann,1 Olga V. Oskolkova,4 Susanne Aschermann,5 Wolfgang Bicker,6 Natacha Ipseiz,1,2
Kerstin Sarter,1 Benjamin Frey,3 Tobias Rothe,1,2 Reinhard Voll,1 Falk Nimmerjahn,5 Valery N. Bochkov,4 Georg Schett,1
and Gerhard Kro¨nke1,2,*
1Department of Internal Medicine 3 and Institute for Clinical Immunology
2Nikolaus Fiebiger Center of Molecular Medicine, University Hospital Erlangen
3Department of Radiation Oncology
University of Erlangen-Nuremberg, 91054 Erlangen, Germany
4Department of Vascular Biology and Thrombosis Research, Center for Physiology and Pharmacology, Medical University of Vienna,
1090 Vienna, Austria
5Department of Biology, Institute of Genetics, University of Erlangen-Nuremberg, 91058 Erlangen, Germany
6FTC-Forensic-Toxicological Laboratory Ltd., 1090 Vienna, Austria
*Correspondence: gerhard.kroenke@uk-erlangen.de
DOI 10.1016/j.immuni.2012.03.010SUMMARY
Noninflammatory clearance of apoptotic cells (ACs)
is crucial to maintain self-tolerance. Here, we have
reported a role for the enzyme 12/15-lipoxygenase
(12/15-LO) as a central factor governing the sorting
of ACs into differentially activated monocyte
subpopulations. During inflammation, uptake of
ACs was confined to a population of 12/15-LO-
expressing, alternatively activated resident macro-
phages (resMF), which blocked uptake of ACs into
freshly recruited inflammatory Ly6Chi monocytes in
a 12/15-LO-dependent manner. ResMF exposed
12/15-LO-derived oxidation products of phosphati-
dylethanolamine (oxPE) on their plasma membranes
and thereby generated a sink for distinct soluble
receptors for ACs such asmilk fat globule-EGF factor
8, which were essential for the uptake of ACs into
inflammatory monocytes. Loss of 12/15-LO activity,
in turn, resulted in an aberrant phagocytosis of ACs
by inflammatory monocytes, subsequent antigen
presentation of AC-derived antigens, and a lupus-
like autoimmune disease. Our data reveal an unex-
pected key role for enzymatic lipid oxidation during
the maintenance of self-tolerance.
INTRODUCTION
Apoptosis as well as the consecutive removal of apoptotic cells
(ACs) are essential to ensure regular tissue turnover and homeo-
stasis (Elliott and Ravichandran, 2010). In this respect, the effi-
cient and nonimmunogenic clearance of ACs is crucial to
dispose self-antigens and to maintain self-tolerance (Elliott and
Ravichandran, 2010; Mun˜oz et al., 2010). In the steady state
and in noninflamed tissue, this task is primarily performed by
alternatively activated, tissue-resident macrophages, which are
involved in tissue repair and homeostasis (Geissmann et al.,834 Immunity 36, 834–846, May 25, 2012 ª2012 Elsevier Inc.2010; Gordon and Taylor, 2005). During inflammation and inflam-
matory tissue damage, however, inflammatory monocytes,
which are defined as Ly6ChiCD11b+CD115+ cells, are rapidly re-
cruited and invade the tissue (Geissmann et al., 2003; Shi and
Pamer, 2011). These cells not only contribute to the uptake
and eradication of pathogens but also have the capacity to
ingest self-antigens and ACs. Notably, inflammatory monocytes
differentiate into inflammatory macrophages and inflammatory
dendritic cells (Auffray et al., 2009; Domı´nguez and Ardavı´n,
2010; Geissmann et al., 2010; Leo´n et al., 2007; Randolph
et al., 1999), which subsequently migrate to lymph nodes,
encounter T cells, and can initiate a protective immune response
against pathogens (Leo´n et al., 2007; Randolph et al., 2008).
Uptake and processing of ACs by inflammatory monocytes will
therefore eventually result in an activation of self-reactive
T cells and a break of self-tolerance (Green et al., 2009). Mech-
anisms that coordinate the clearance of ACs and thereby limit
the uptake of self-antigens by inflammatory monocytes are still
poorly understood, though.
The enzyme 12/15-lipoxygenase (12/15-LO) represents the
murine ortholog of human 15-lipoxygenase and oxygenates
both free and phospholipid-bound polyunsaturated fatty acids
(Kuhn and Thiele, 1999). Expression of 12/15-LO is restricted
to certain macrophage subsets and induced upon stimulation
with interleukin-4 (IL-4) and IL-13. Such 12/15-LO-expressing
macrophage populations include alternatively activated macro-
phages and macrophages participating in the resolution of
inflammation (Brys et al., 2005; Gordon andMartinez, 2010; Hey-
deck et al., 1998; Kuhn and Thiele, 1999; Schif-Zuck et al., 2011;
Stables et al., 2011). Although 12/15-LO has been recognized as
a major factor promoting the oxidation of LDL particles and the
pathogenesis of atherosclerosis, the physiological role of this
enzyme has remained incompletely understood (Kuhn and
Thiele, 1999). Several studies indicate that 12/15-LO can
contribute to the generation of proresolving lipid mediators
such as lipoxin A4, resolvin E1, and protectin D1. These lipid
mediators, in turn, are identified as important factors initiating
the resolution of inflammation and have been additionally impli-
cated in the removal of apoptotic cells and the wound-healing
process (Godson et al., 2000; Gronert et al., 2005; Kro¨nke
Figure 1. Uptake of ACs Is Confined to 12/
15-LO-Expressing Macrophages
(A and B) Immunofluorescence (IF) microscopy
analysis of the phagocytosis of (A) apoptotic cells
(AC; green) and (B) heat-killed E. coli bacteria
(green) by macrophages that were isolated from
thioglycollate-induced peritonitis exudates.
Staining for 12/15-LO (blue) and F4/80 (red) were
performed as indicated.
(C) IF microscopy of 12/15-LO (blue) and Tim-4
(green) expression in macrophages isolated from
peritonitis exudates of WT and Alox15/ animals.
Staining for Tim-4 allowed identifying resMF in
exudates ofAlox15/ animals. Arrows point to the
12/15-LO- and Tim-4-expressing resMF.
(D andE) Flow cytometry analysis of the 12/15-LO-,
Tim-4-, and Ly6C-expressing subpopulations of
cells that are present in exudates of a thio-
glycollate-induced peritonitis (in WT and Alox15/
mice) at day 3 after induction of peritonitis. Thedata
shown here are representative for at least three
independent experiments.
Scale bars represent 10 mm. See also Figure S1.
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12/15-LO Mediates Self-Toleranceet al., 2009; Merched et al., 2008; Schwab et al., 2007; Serhan,
2010; Serhan et al., 2008). Interestingly, 12/15-LO is reported
to translocate to the macrophages’ plasma membrane during
the phagocytosis of ACs (Miller et al., 2001). The implication
behind this phenomenon as well as a potential role for 12/15-LO
during the uptake of ACs has remained elusive, though.
Here we have identified the enzyme 12/15-LO as a crucial
factor orchestrating the sorting of ACs during inflammation,
where the clearance of ACs was primarily performed by
a subpopulation of alternatively activated, 12/15-LO-expressing
residentmacrophages (resMF). These resMF inhibited uptake of
ACs by freshly recruited inflammatory monocytes in a 12/15-LO-
dependent manner. Furthermore, we have identified 12/15-LO-
derived oxidation products of phosphatidylethanolamine as the
corresponding inhibitory mediators generated by resMF.
Absence of 12/15-LO, in turn, resulted in an unsorted clearance
of ACs and enhanced uptake of apoptotic material by inflamma-
tory monocytes, which triggered a subsequent T cell response
against antigens derived from ACs. In line with these results,
12/15-LO-deficient animals displayed a break of self-tolerance
and, with increasing age, developed a lupus-like autoimmune
disease. On a mechanistic level, the identified 12/15-LO-derived
phospholipid oxidation products were enriched in the plasma
membrane of resMFwhere they sequestered and bound distinct
soluble receptors for ACs such as milk fat globule-EGF factor 8Immunity 36, 834–(MFG-E8), which were exclusively ex-
pressed and utilized by inflammatory
monocytes and inflammatory macro-
phages. Thereby these oxidized phos-
pholipids specifically interfered with the
uptake of ACs into these proinflammatory
cells.
Our data point toward a role for enzy-
matic lipid oxidation during the mainte-
nance of self-tolerance and identify
a mechanism that orchestrates the cell-and context-specific uptake of antigens by different subsets of
phagocytes, imposing a paradigm in our understanding of the
clearance of apoptotic cells.
RESULTS
Clearance of ACs Is Confined to 12/15-LO-Expressing
Resident Macrophages
To study regulativemechanisms underlying the clearance of ACs
during inflammation, we determined phagocytosis of ACs during
thioglycollate-induced peritonitis. Apoptotic thymocytes were
used as ACs in all experiments. Interestingly, in elicited macro-
phages of peritonitis exudates, phagocytosis of carboxyfluores-
cein diacetate succinimidyl ester (CFSE)-labeled ACs was
largely confined to a certain subpopulation of macrophages,
which highly expressed the enzyme 12/15-LO (Figure 1A). In
contrast, phagocytosis of bacteria showed an inverse pattern
of uptake and was mainly performed by the population of 12/
15-LO-negative cells (Figure 1B). Immunofluorescence (IF)
microscopy of elicited macrophages as well as flow cytometry
analysis of the total cellular content in peritonitis exudates
showed that the population of 12/15-LO-expressing macro-
phages coexpressed the phosphatidylserine-binding receptor
Tim-4 and accounted for approximately 3% of total cells in
exudates (Figures 1C and 1D, population P1). In contrast, the846, May 25, 2012 ª2012 Elsevier Inc. 835
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12/15-LO Mediates Self-Tolerancemajor fraction of 12/15-LO-negative cells consisted of inflamma-
tory Ly6Chi monocytes, which coexpressed markers such as
CCR2 and CD62L (Figure 1E, population P2; Figures S1A and
S1B available online). The other cellular subsets in the exudates
included neutrophils and B cells (data not shown).
The subsequent analyses identified the 12/15-LO-expressing
macrophages within the peritonitis as resident peritoneal macro-
phages (resMF), which coexpressed 12/15-LO and Tim-4. After
induction of peritonitis, these resMF were outnumbered by
newly recruited inflammatory monocytes (Figures S1C–S1E).
12/15-LO Orchestrates the Cell Type-Specific Uptake
of ACs during Inflammation
The confined phagocytosis of ACs by 12/15-LO-expressing
resMF prompted us to elucidate a potential role for 12/15-LO
during the clearance of ACs. Initial experiments showed that
a pure homogenous population of Tim-4+ resMF, isolated
from WT or 12/15-LO-deficient (Alox15/) mice, ingested
equally high amounts of ACs (Figures 2A and 2B). These data
excluded an intrinsic role of 12/15-LO during the ingestion of
ACs and showed that this enzyme was not required for the
uptake of ACs into the subpopulation of 12/15-LO-expressing
resMF.
The analysis of the clearance of ACs during peritonitis,
however, revealed an unexpected and crucial role for 12/15-
LO during the sorting of ACs into the different subpopulations
of monocytes and macrophages. Although we consistently
observed the confined uptake of ACs by 12/15-LO+Tim-4+
resMF in exudates from WT animals, inflammatory exudates
from 12/15-LO-deficient mice displayed an increased and dis-
torted phagocytosis of ACs. Here, ACs were increasingly taken
up by newly recruited inflammatory monocytes and macro-
phages (Figures 2C and 2D).We also observed this phenomenon
in vivo, where the absence of 12/15-LO during peritonitis re-
sulted in a redirection of the uptake of ACs toward the population
of inflammatory Ly6Chi monocytes (Figure 2E). Staining for Tim-4
allowed the identification of resMF in exudates from Alox15/
mice. This analysis confirmed that, in the absence of 12/15-
LO, the uptake of ACs was shifted to the population of recruited
inflammatory cells, although resMF were still capable of ingest-
ing ACs (Figure 2F).
These observations therefore prompted us to hypothesize that
resMF possess the intrinsic capacity to actively inhibit the
uptake of ACs by inflammatory monocytes in a paracrine- and
12/15-LO-dependent manner.
Resident Macrophages Utilize 12/15-LO to Generate
Specific Phospholipid Oxidation Products
We consequently sought to determine the identity of potential
12/15-LO-derived mediator(s) in resMF, which interfere with
the uptake of ACs by inflammatory monocytes. Although this
enzyme can participate in the generation of different classes of
eicosanoids, 12/15-LO was recently shown to preferentially
oxygenate esterified fatty acids in the form of membrane-bound
phosphatidylethanolamine (PE), although the biological conse-
quence of this oxidation process remains largely elusive (Ma-
skrey et al., 2007; Morgan et al., 2009). Analysis of phospholipids
in resMF by mass spectrometry confirmed the presence of
12/15-LO-specific PE oxidation products in this macrophage836 Immunity 36, 834–846, May 25, 2012 ª2012 Elsevier Inc.subpopulation. WT resMF were enriched in PE hydroxides
(PAPE-OH) and PE hydroperoxides (PAPE-OOH), which were
both absent in Alox15/ resMF (Figures 3A–3C). In contrast,
we detected equal amounts of nonoxidized PE (PAPE) in WT
and Alox15/ resMF (Figure 3D). Quantification of PAPE-OH
by mass spectrometry showed an increased production of
PAPE-OH during later phases of the peritonitis in vivo coinciding
with the resolution phase of inflammation (Figure 3E). 12/15-LO
was shown to oxidize PAPE directly within the plasma
membrane (Morgan et al., 2009). Concentrations of cell-associ-
ated PAPE hydro(pero)xides were calculated to reach 0.3 to
1.5 mmol/l within the resMF assuming a cellular volume of
460 fl (Nibbering et al., 1990).
Oxidation Products of PE Selectively Interfere
with the Uptake of ACs into Inflammatory Monocytes
Consequently, we studied the capacity of various species of
oxidized phospholipids to interfere with the ingestion of ACs
by inflammatory monocytes. Indeed, intraperitoneal (i.p.) appli-
cation of oxidized PE (oxPE) blocked the uptake of ACs by
inflammatory Ly6Chi monocytes during peritonitis in Alox15/
mice (Figure 4A). In 12/15-LO-deficient animals, oxPE thereby
ameliorated the uptake of ACs by inflammatory monocytes to
amounts seen in WT mice. Additional in vitro experiments
confirmed that oxidized phospholipids blocked the uptake of
ACs in a dose-dependent manner (Figure 4B). Here we tested
the effect of different species of phospholipid oxidation prod-
ucts including oxPE, oxidized phosphatidylcholine (oxPC), and
oxidized phosphatidylserine (oxPS) on the uptake of ACs by
inflammatory macrophages, which were isolated from perito-
nitis exudates. In this set of experiments, oxPE showed by far
the highest potency and displayed high activity at low concen-
trations (1 mM). In addition, we performed site-specific enzy-
matic oxidation of PE by soybean 15-lipoxygenase, which
resulted in the generation of specific PE oxidation products
(15-PAPE-OH and 15-PAPE-OOH). Here, 15-PAPE-OOH ex-
erted similar biologic activity as oxPE and potently blocked
the uptake of ACs into inflammatory macrophages (Figure 4C).
Oxidation of PE was a prerequisite for its biologic activity, as
shown by the fact that nonoxidized PE had no effect on the
ingestion of ACs (Figure 4D). Phagocytosis of latex beads,
bacteria, mannosylated albumin, or dextran particles was not
blocked (Figure 4E), demonstrating that oxPE did not interfere
with the process of phagocytosis in general. Importantly, addi-
tion of oxPE did not affect the phagocytosis of ACs by the pop-
ulation of 12/15-LO+Tim-4+ resMF. Here, oxPE had an effect
neither on a culture of pure resMF (Figure 4F) nor on Tim-4-
positive resMF, which were still present in the inflammatory
exudates (Figure 4G). These data show that oxPE selectively
acted on inflammatory monocytes and macrophages. In turn,
the addition of oxPE rescued the selective phagocytosis of
ACs by Tim-4+ resMF during peritonitis even in the absence
of 12/15-LO (Figure 4G).
Together these data demonstrate that oxPE is able to exert
a context- and cell type-specific inhibition of the phagocytosis
of ACs. Furthermore, these results strongly indicate that
oxPE largely accounts for the activity of 12/15-LO during the
sorting of ACs into different macrophage and monocyte
subpopulations.
Figure 2. 12/15-LO Orchestrates the Phagocytosis of ACs
(A and B) IF microscopy-based (A) and flow cytometry-based (B) analysis of the phagocytosis of CFSE-labeled ACs (green) by a population of pure resMF from
WT and Alox15/ animals.
(C and D) IF microscopy-based (C) and flow cytometry-based (D) analysis of the phagocytosis of CFSE-labeled ACs by macrophages of peritonitis exudates of
WT and Alox15/ animals. Data here are representative for three independent experiments.
(E) Flow cytometry-based quantification of the phagocytosis of CFSE-labeled ACs by Ly6Chi inflammatory monocytes in vivo. During thioglycollate-induced
peritonitis, CFSE-labeled ACs were injected i.p. 30 min before phagocytosis of ACs was determined by flow cytometric analysis (representative of three inde-
pendent experiments).
(F) IF microscopy-based analysis of the phagocytosis of ACs by macrophages of peritonitis exudates of WT and Alox15/ animals. An antibody against Tim-4
(red) was used to identify resMF both in WT and Alox15/ exudates and to differentiate these cells from recruited inflammatory macrophages. Arrows point at
residual resMF. The data shown are representative for at least three experiments.
Error bars indicate SD. Scale bars represent 10 mm.
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12/15-LO Mediates Self-Tolerance12/15-LO-Mediated Sorting of ACs Is Required for the
Nonimmunogenic Disposal of Self-Antigens
To elucidate possible immunological consequences resulting
from the sorting of ACs into different monocyte andmacrophage
subpopulations, we further characterized these populations ofcells. After stimulation with LPS, resMF displayed characteris-
tics of alternatively activated macrophages including elevated
production of the anti-inflammatory cytokines IL-10 and
TGF-b, whereas the subset of inflammatory macrophages was
biased toward production of IL-12 and TNF-a (Figure 5A). TheseImmunity 36, 834–846, May 25, 2012 ª2012 Elsevier Inc. 837
Figure 3. ResMF Are Enriched with 12/15-LO-Specific Oxidation Products
(A and B) Electrospray-ionization mass spectrometry (ESI-MS)-based analysis of (A) PE-hydroxides (PAPE-OH) and (B) PE-hydroperoxides (PAPE-OOH) in lipid
extracts from WT and Alox15/ resMF.
(C) After quantification of PAPE-OH in WT and Alox15/ resident macrophages, cell-associated concentrations of this phospholipid were calculated, assuming
a volume of 460 fl per macrophage.
(D) Analysis of nonoxidized PE (PAPE) in WT and Alox15/ resident macrophages.
(E) ESI-MS-based quantification of the amounts of PAPE-OH at the indicated time points (0, 3, and 7 days) in cells of the peritoneal exudates of WT and Alox15/
mice after thioglycollate challenge. Concentrations of cell-associated PAPE-OH within the resident macrophages were calculated on the basis of the number of
resident macrophages present within the peritonitis exudates (and assuming a volume of 460 fl per macrophage).
See also Table S1.
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12/15-LO Mediates Self-Tolerancedata are consistent with a tolerogenic role of resMF (Geissmann
et al., 2010; Murray and Wynn, 2011) and the proposed role of
inflammatory Ly6Chi monocytes, which can differentiate into
inflammatory macrophages and dendritic cells, thereby gaining
antigen-presenting capacity (Auffray et al., 2009; Domı´nguez
and Ardavı´n, 2010; Geissmann et al., 2003; Leo´n et al., 2007;
Randolph et al., 1999, 2008; Shi and Pamer, 2011). Antigens in-
gested by inflammatorymonocytes andmacrophages are there-
fore, to a certain extent, presented to T cells (Geissmann et al.,
2003; Randolph et al., 2008). Hence, a nondirected sorting
process of ACs during inflammation would eventually result in
the presentation of autoantigens to potentially self-reactive
T cells.
To test this hypothesis, we subsequently determined the
consequences of a directed versus nondirected sorting of ACs
on the immune response to AC-derived antigens in WT and 12/
15-LO-deficient animals, respectively. ACs were generated
from ovalbumin (OVA)-transgenic mice and incubated with
different populations of macrophages. Thereafter, we measured
the T cell response to OVA as an AC-derived antigen by moni-
toring the response of OVA-specific OT-II T cells in antigen-
presentation assays. Phagocytosis of OVA transgenic-ACs by
neither WT nor 12/15-LO-deficient resMF did induce a specific
T cell response (Figure 5B). These data are in accordance with
our previous results and confirm a tolerogenic role of resMF,838 Immunity 36, 834–846, May 25, 2012 ª2012 Elsevier Inc.which perform a nonimmunogenic disposal of AC-derived anti-
gens in a 12/15-LO-independent manner. Next, we isolated
macrophages from peritonitis exudates, thereby obtaining an
assortment of resMF and inflammatory macrophages as poten-
tial antigen-presenting cells. Here, phagocytosis of OVA-trans-
genic ACs bymacrophages that were isolated fromWTexudates
did not result in a T cell response to AC-derived OVA, either (Fig-
ure 5C). In contrast, we observed a specific T cell response to the
AC-derived antigen when we used macrophages from exudates
ofAlox15/ animals as antigen-presenting cells (Figure 5C). The
addition of oxPE reversed this phenotype (Figure 5C). These
results thereby confirmed that a directed 12/15-LO-mediated
sorting process and uptake of ACs by resMF contributes to
a nonimmunogenic disposal of AC-derived antigens. The
absence of 12/15-LO during inflammation, which resulted in
a distorted clearance and enhanced uptake of ACs by inflamma-
tory monocytes, however, provoked a subsequent activation of
antigen-specific T cells to AC-derived antigens. To exclude
a cell-intrinsic effect as base for the increased stimulatory
capacity of Alox15/ cells, we subsequently exchanged soluble
OVA for OVA-transgenic ACs as an antigen. Here, uptake and
processing of soluble OVA by both WT and Alox15/ exudates
macrophages resulted in robust T cell responses (Figure 5D). In
accordance, exudate macrophages of WT and Alox15/
animals displayed a similar expression of costimulatory
Figure 4. Oxidized Phosphatidylethanolamine Selectively Blocks
the Uptake of ACs by Inflammatory Monocytes
(A) Flow cytometry-based in vivo analysis of the phagocytosis of CFSE-labeled
ACs by Ly6Chi inflammatory monocytes during thioglycollate-induced perito-
nitis after i.p. injection of ACs in the presence or absence of oxPE (10 mM). Error
bars indicate SD.
(B–D) Flow cytometry-based quantification of the uptake of CFSE-labeled ACs
by macrophages of peritonitis exudates of WT and Alox15/ mice, in the
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12/15-LO Mediates Self-Tolerancemolecules (data not shown). Likewise, we detected no differ-
ences in the cytokine production of WT and Alox15/ macro-
phages after ingestion of ACs (Figure 5E), which ruled out
a role of 12/15-LO as a secondary mediator of potential anti-
inflammatory effects of ACs. Together these results confirmed
that 12/15-LO activity was crucially involved in the adjustment
of a threshold for a T cell response against AC-derived self-anti-
gens by coordinating the sorting of ACs.
We subsequently sought to determine whether the aberrant
clearance of ACs inAlox15/ animalswould also result in a T cell
response against AC-derived antigens in vivo. Therefore we
transferred OT-II T cells into WT and Alox15/ mice, induced
peritonitis, and injected OVA-transgenic ACs into the perito-
neum. In accordance with our in vitro data, we observed an
OVA-specific T cell response in the draining mediastinal lymph
nodes and spleens of Alox15/ mice, whereas OT-II cells did
not respond to this AC-derived antigen, when transferred to
WT mice. OT-II cells in nondraining mesenteric lymph nodes
showed no response at all (Figure 5F).
Absence of 12/15-LO Results in a Break
of Self-Tolerance
Consequently, we analyzed whether the distorted clearance of
ACs in Alox15/ mice compromised their state of self-toler-
ance. Interestingly, aged 12/15-LO-deficient mice have been
recently reported to display splenomegaly aswell as a decreased
survival when compared to their WT littermates (Middleton et al.,
2006). Whether these findings can be attributed to a potential
hematological disorder has been controversially discussed
(Van Etten, 2007). The possibility of an autoimmune disorder in
these mice had not been addressed, though.
Serum analysis of aged 12/15-LO-deficient mice revealed the
emergence of anti-nuclear antibodies as a hallmark of systemic
autoimmunity (Figure 6A). Consistent with a major role of
12/15-LO in the maintenance of self-tolerance, we detected
a significant and spontaneous production of several forms of
autoantibodies in aged 12/15-LO-deficient mice including anti-
dsDNA, anti-cardiolipin, and anti-histone autoantibodies (Fig-
ure 6B). Likewise, 12/15-LO-deficient mice spontaneously
developed signs of glomerulonephritis and showed deposits of
complement and immunoglobulins within their glomeruli (Figures
6C, S3A, and S3B).
Consequently we performed the pristane model of experi-
mental murine lupus, where simultaneous induction of sterile
peritonitis and apoptosis trigger production of autoantibodies
and the development of glomerulonephritis, all resembling keypresence of the indicated (B) oxidized, (C) enzymatically (soybean-15-LO)
generated, or (D) nonoxidized phospholipid.
(E) Flow cytometry-based quantification of the uptake of labeled latex beads,
E. coli, mannosylated BSA, or dextran by macrophages of peritonitis exudates
in the presence of increasing concentrations of oxPE.
(F) Quantification of the uptake of apoptotic cells by a population of pure
resMF in the presence of increasing amounts of oxPE.
(G) IF microscopy of WT and Alox15/ macrophages of peritonitis exudates
after incubation with CFSE-labeled ACs in the absence or presence of oxPE
(10 mM). An antibody against Tim-4 (red) was used to identify resMF both inWT
and Alox15/ exudates and to differentiate these cells from recruited
inflammatory macrophages. Scale bars represent 10 mm.
Data shown are representative of at least three experiments.
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Figure 5. 12/15-LO Mediates the Nonimmunogenic Disposal of AC-Derived Antigens
(A) Determination of the cytokine profile of resMF and inflammatory macrophages. Concentrations of the indicated cytokines in the cellular supernatants were
measured by ELISA after stimulation of macrophages with LPS (100 ng/ml; 12 hr).
(B and C) Determination of the OT-II T cell response against AC-derived OVA via CFSE-dilution assays. ACs of OVA-tg mice were incubated with (B) a population
of pure resMF or (C) macrophages of peritonitis exudates in the absence or presence of oxPE (10 mM). After 24 hr, CFSE-labeled OT-II T cells were added and the
T cell response was measured by CFSE dilution after an additional 72 hr as described in Experimental Procedures.
(D) Determination of the OT-II T cell response to soluble OVA that has been preincubated with macrophages of peritonitis exudates for 24 hr before the addition of
OT-II T cells.
(E) ELISA-based measurement of the cytokine response of macrophages of peritonitis exudates, which had been preincubated with ACs for 2 hr before being
stimulated with LPS (100 ng/ml; 6 hr).
(F) In vivo quantification of the T cell response to OVA-tg ACs, which had been i.p. injected into the inflamed peritoneum. T cell proliferation of transferred CFSE-
labeled OT-II T cells in draining mediastinal lymph nodes, the spleen, and nondraining mesenterial LN was determined by flow cytometric analysis.
Data shown are representative for three experiments. Error bars indicate SD. See also Figure S2.
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Figure 6. 12/15-LODeficiency Results in a Break of
Self-Tolerance
(A) HEp-2 cells were incubated with serum derived from
24-week-old WT and Alox15/ mice to detect anti-
nuclear antibodies (green).
(B) Measurement of the amounts of indicated autoanti-
bodies in sera of WT and Alox15/ mice. Analysis of all
mice was performed at the age of 24 weeks (either in
unchallenged mice or in mice 12 weeks after injection of
pristane oil).
(C) IF microscopy determining complement (c3) deposits
(green) and PAS staining of kidneys from WT and
Alox15/ mice. Analysis of all mice was performed at the
age of 24 weeks (either in unchallenged mice or in mice
12 weeks after injection of pristane oil); F4/80 (red).
(D) Quantification of proteinuria in WT and Alox15/mice
12 weeks after injection of pristane oil.
Scale bars represent 10 mm. See also Figure S3.
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12/15-LO Mediates Self-Tolerancefeatures of human systemic lupus erythematosus (SLE) (Reeves
et al., 2009). As expected, 12/15-LO deficiency provoked an
additional exacerbation of the production of autoantibodies
and glomerulonephritis (Figures 6B, 6C, S3A, and S3B). Here,
Alox15/ mice displayed prominent deposits of PAS-positive
material in their glomeruli (Figure 6C) and increased proteinuria
(Figure 6D).
Oxidation Products of PE Interfere with MFG-E8-
Mediated Uptake of ACs into Inflammatory Monocytes
The ingestion of ACs relies on the receptor-mediated recognition
of phosphatidylserine (PS), which is exposed on the outer leaflet
of the membranes of ACs (Ravichandran, 2010). PS, in turn, is
recognized by a multitude of receptors such as MFG-E8 and
Tim-4 (Hanayama et al., 2002; Miyanishi et al., 2007), which
are differentially expressed by distinct phagocyte subsets.
To further delineate the mechanism underlying the cell-type-
specific inhibition of phagocytosis by 12/15-LO-generated
oxPE, we performed a gene expression analysis of resMF and
inflammatory macrophages to compare their repertoires of
known PS-binding proteins (Figure 7A). Indeed, the two popula-Immunity 36tions of macrophages displayed clear differ-
ences in their PS-receptor profiles. As reported
previously (Miyanishi et al., 2007), expression
of the PS receptor Tim-4 was confined to
resMF, whereas expression of the secreted
PS-binding protein MFG-E8 was restricted to
inflammatory macrophages. MFG-E8 serves as
a bridging molecule between PS on the surface
of the apoptotic cell and avb3-integrin on the
macrophage (Hanayama et al., 2002). MFG-E8
was shown to be essential for the phagocytosis
of ACs by inflammatory macrophages (Ha-
nayama et al., 2004), whereas resMF rely on
different molecules such as Tim-4 (Miyanishi
et al., 2007; Wong et al., 2010). We therefore
determined whether oxPE can interfere with
the binding of MFG-E8 to PS, which would
account for the oxPE-mediated selective block
of phagocytosis in inflammatory macrophages.In competitive binding assays, we tested for the potency of
different phospholipid vesicles to interfere with the binding of
MFG-E8 to a PS-coated surface (Figure 7B). Indeed, vesicles
containing oxPE potently blocked binding of MFG-E8 to PS,
whereas vesicles containing nonoxidized PE did not (Figure 7B).
As expected, PS-containing vesicles blocked binding of MFG-
E8 to PS in an oxidation-independent manner (Figure 7B). These
data indicate an oxidation-dependent and competitive binding
of oxPE to the PS-binding molecule MFG-E8. The addition of
increasing amounts of recombinant MFG-E8, in turn, reconsti-
tuted the ability of inflammatory macrophages to ingest ACs in
the presence of oxPE (Figure 7C), confirming a role of MFG-E8
as a functional target of oxPE.
Upon 12/15-LO-mediated oxidation, PEwas shown to translo-
cate to the outer leaflet of the plasma membrane in resMF
(Morgan et al., 2009). We therefore determined binding of re-
combinant MFG-E8 to the plasma membrane of resMF. These
experiments were performed in the presence of RGD peptides
to exclude integrin-dependent binding of MFG-E8. Indeed,
MFG-E8 was strongly bound by 12/15-LO-expressing resMF,
whereas deletion of 12/15-LO abrogated MFG-E8 binding in, 834–846, May 25, 2012 ª2012 Elsevier Inc. 841
Figure 7. OxPE Blocks the Interaction between
MFG-E8 and Phosphatidylserine
(A) Differential expression of various receptors for ACs in
resMF and inflammatory macrophages.
(B) Binding of recombinant MFG-E8 to a PS-coated
surface in the presence of vesicles containing the indi-
cated phospholipids as competitors.
(C) Flow cytometry-based quantification of the uptake of
CFSE-labeled apoptotic cells by macrophages of perito-
nitis exudates in the presence of increasing concentra-
tions of oxPE and different concentrations of recombinant
MFG-E8, respectively.
(D) Binding of recombinant MFG-E8 (green) to the surface
of WT and Alox15/ (pure) resMF in the presence of RGD
peptides; DAPI (blue). Scale bars represent 10 mm.
Error bars indicate SD for triplicates.
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12/15-LO Mediates Self-ToleranceAlox15/ resMF (Figure 7D). Together these observations indi-
cate that upon exposure of oxPE, resMF sequester soluble
MFG-E8 in a 12/15-LO-dependent manner and thereby selec-
tively interfere with the phagocytosis of ACs by inflammatory
monocytes and macrophages (Figure S3).
DISCUSSION
Efficient elimination of pathogens and the maintenance of self-
tolerance are key objectives during the immune response.
Failure to do so results in fatal infection or autoimmune disease,
respectively (Green et al., 2009). During inflammation and tissue
damage, the innate immune system is simultaneously con-
fronted with both pathogens and self-antigens in the form of
ACs. Therefore, regulative mechanisms controlling the uptake
and processing of ACs are crucial in the maintenance of toler-
ance (Mun˜oz et al., 2010). Our current data show that at a very
early stage, and in particular during inflammation, the innate842 Immunity 36, 834–846, May 25, 2012 ª2012 Elsevier Inc.immune system performs a sorting of patho-
gens and ACs into distinct subsets of phago-
cytes. During the last two decades, multiple,
and probably equally important, ‘‘tolerance
checkpoints’’ have been identified, which coop-
erate to prevent a break of self-tolerance. Such
tolerance-prevailing mechanisms include direct
anti-inflammatory effects of apoptotic cells,
which thereby modulate the phagocyte’s cyto-
kine profile directly (Fadok et al., 1998; Voll
et al., 1997). Likewise, recent data suggest
that a selection and sorting process of antigens,
which are derived from ACs and pathogens,
respectively, is also performed at the level of
phagosome maturation. Here, the activation of
Toll-like receptors influences the fate of the
single phagosome within the phagocyte (Blan-
der andMedzhitov, 2004, 2006a, 2006b). There-
fore it is obvious thatmultiplemechanisms regu-
lating the sorting, uptake, and processing of
ACs have evolved in response to the evolu-
tionary pressure exerted by the ‘‘horror autotox-
icus.’’ Together these mechanisms set up
a certain threshold for self tolerance, whichmight considerably vary in a context-dependent manner as
observed during different types of infection, during sterile inflam-
mation, or in the tumor microenvironment.
Indeed, our current data provide evidence that the sorting of
ACs is decisive for the quality of the subsequent immune
response to AC-derived antigens. ResMF and inflammatory
monocytes, which both have the capacity to participate in the
uptake of ACs, are of distinct origin and activation status. Alter-
natively activated tissue-resident macrophages, which express
both TGF-b and IL-10, have already been implicated in the clear-
ance of ACs, tissue repair, the resolution of inflammation, and the
maintenance of immunological tolerance (Geissmann et al.,
2010; Gordon and Taylor, 2005; Green et al., 2009; Murray and
Wynn, 2011). Nevertheless, direct evidence for their role during
these processes has been scarce so far. In contrast, Ly6Chi
inflammatory monocytes, which are actively blocked in their
capacity to engulf ACs in a 12/15-LO-dependent manner, are
well-known precursors of inflammatory macrophages and
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nguez and Ardavı´n, 2010; Geissmann et al., 2010; Gordon and
Taylor, 2005; Randolph et al., 1999, 2008). In accordance with
this scenario, we observed that an aberrant sorting process
and ingestion of ACs by inflammatory monocytes resulted in
the presentation of AC-derived antigens to T cells and in a break
of self-tolerance as observed in 12/15-LO-deficient mice.
On a molecular level, our data suggest that the crosstalk
between resMF and their inflammatory counterparts is accom-
plished by exposure of oxidized phospholipids in a 12/15-LO-
dependent manner. Here, oxidized phospholipids generated by
alternatively activated macrophages selectively interfere with
the uptake of ACs by proinflammatory monocytes. Besides the
oxygenation of such membrane phospholipids, 12/15-LO has
been implicated in the production of different classes of prore-
solving lipid mediators such as lipoxin A4 (Gronert et al., 2005;
Merched et al., 2008; Serhan et al., 2008). Lipoxin A4 was previ-
ously shown to enhance the nonphlogistic phagocytosis of
apoptotic neutrophils by human monocyte-derived macro-
phages (Godson et al., 2000). Together with our present data,
these findings suggest that distinct 12/15-LO-derived eicosa-
noids such as lipoxin A4 might facilitate uptake of AC by alterna-
tively activated macrophages, whereas other 12/15-LO-derived
lipid oxidation products such as oxPE simultaneously block
uptake of ACs by inflammatory monocytes. Both mechanisms
would eventually contribute to a sorted and noninflammatory
clearance of ACs by the alternatively activated macrophage.
The production both of proresolving eicosanoids and of oxPE
coincides with the resolution of inflammation. Although most
eicosanoids have been identified as high-affinity ligands for
specific receptors and exert their effects at low concentrations
in the nM range (Serhan et al., 2008), our current data suggest
that 12/15-LO-derived oxidized phospholipids might act in
a different manner. OxPE seems to exert its biological activity
in the low mM range, at least in part, via sequestering and block-
ing distinct soluble pattern recognition receptors (PRRs) such as
MFG-E8, which are otherwise selectively utilized by inflamma-
tory monocytes for the purpose of phagocytic uptake of ACs.
Even single oxPE species such as PAPE-OH (PAPE reflects
around 20%–30%of total PE) are detected in mMconcentrations
within resMF. Moreover, oxPE is enriched in the outer
membrane leaflet in a 12/15-LO-dependent manner (Morgan
et al., 2009), which might yield even higher local concentrations.
Although we identify MFG-E8 as a major target for oxPE,
previous studies have demonstrated that related species of
oxidized phospholipids can also interact with other PRRs such
as CD36 and CD14, which have been implicated in the binding
and uptake of ACs as well (Blu¨ml et al., 2005; Bochkov et al.,
2002; Devitt et al., 1998; Greenberg et al., 2006; von Schlieffen
et al., 2009). Future studies are needed to define the exact contri-
bution and role of these different PRRs during the sorting of ACs.
MFG-E8 is produced by various cells including follicular
dendritic cells, monocyte-derived dendritic cells, and inflamma-
tory macrophages (Ravichandran, 2010). Because of a defective
clearance of ACs in the germinal centers of the spleen, MFG-E8-
deficient mice themselves spontaneously develop autoimmunity
(Hanayama et al., 2004). On the other hand, intravenous or intra-
peritoneal injection of recombinant MFG-E8 into WT mice
equally results in a break of tolerance and triggers the develop-ment of autoantibodies (Asano et al., 2004; Yamaguchi et al.,
2010). Moreover, sustained or elevated serum concentrations
of MFG-E8 are associated with an increased risk for human
SLE (Yamaguchi et al., 2008, 2010). Together with our current
data, these findings indicate that MFG-E8-dependent phagocy-
tosis of ACs by macrophages and dendritic cells has to be care-
fully regulated in a site-, context-, and cell-specific manner.
During infection, MFG-E8-dependent uptake of ACs by dendritic
cells and inflammatory monocytes might be important to mount
an immune response to efficiently eradicate intracellular patho-
gens. Uncontrolled ingestion of ACs by inflammatory antigen-
presenting cells critically lowers the threshold of self-tolerance,
though. Our current data may provide an explanation for the
redundancy in PS-binding molecules. Here, the cell type-
specific expression patterns of proteins like Tim-4 and MFG-
E8 are a prerequisite for the observed crosstalk between resMF
and inflammatory monocytes and allow a rapid and flexible regu-
lation of the clearance of ACs.
Previous studies highlighted a major role of 12/15-LO during
the oxidation of LDL and the pathogenesis of atherosclerosis
(Cyrus et al., 1999, 2001; George et al., 2001). Nevertheless,
the physiological role of this evolutionary highly conserved
enzyme has remained elusive so far (Kuhn and Thiele, 1999).
Our current findings on the role of 12/15-LO in the maintenance
of tolerance highlight a role of lipid oxidation, which lies beyond
cardiovascular disease. Hence it is compelling to speculate that
enhanced lipid oxidation and the consecutive development of
atherosclerosis are part of the price we pay for immunological
tolerance.
EXPERIMENTAL PROCEDURES
Animals
Animal experiments were approved by the government of Mittelfranken. Mice
were housed in the animal facility of the University of Erlangen-Nuremberg.
12/15-LO-deficient (Alox15/), ovalbumin transgenic (OVAtg), and OT-II
mice were purchased from The Jackson Laboratory; C57BL/6 mice were
purchased from Charles River Laboratories.
Phagocytosis Assay
Resident macrophages were isolated from the peritoneum of naive 10- to 12-
week-old mice. Inflammatory macrophages were isolated from peritonitis
exudates, 72 hr after intraperitoneal injection of 2.5 ml of 3% Brewer’s thiogly-
collate (Sigma-Aldrich) intoWT and Alox15/mice at the age of 10–12 weeks.
Both elicited and resident peritoneal macrophages were obtained by perito-
neal lavage with ice-cold 4% FCS in PBS and plated in 48-well plates for
flow cytometry analysis and on coverslips in 24-well plates for immunofluores-
cence microscopy, respectively. Macrophages were allowed to rest overnight
at 37C at 5% CO2 before starting experiments. To generate apoptotic cells,
thymocytes isolated from 6- to 8-week-old female C57BL/6mice were labeled
with CFSE (Sigma-Aldrich) and afterwards incubated for 6 hr in 1 mM dexame-
thason, washed several times with PBS, spun through a FCS cushion to
eliminate the dexamethason, and resuspended in 10% FCS in RPMI. Macro-
phages were incubated with apoptotic cells in 10% FCS in RPMI for 30 min
at a ratio of 1:5 at 37C. For phagocytosis of bacteria, E. coli were heat inacti-
vated, CFSE labeled, and incubated with macrophages at a ratio of 1:50 for
30 min at 37C. Afterward, unbound cells were gently washed away with
ice-cold PBS. For flow cytometry, macrophages were detached with trypsin
and EDTA, transferred into plastic tubes, and stained if indicated at 4C for
30 min. Analysis was performed with a GALLIOS cytofluorometer (Beckmann
Coulter) and FlowJo software. The number of CFSE-positive macrophages
was determined and relative uptake was calculated by normalization to the
WT control (=1). For immunofluorescence microscopy, macrophages onImmunity 36, 834–846, May 25, 2012 ª2012 Elsevier Inc. 843
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was performed with an Eclipse-80i microscope (Nikon) and a monochromatic
camera (DS-Qi1MC; Nikon). Pictures are displayed with indicated pseudocol-
ors by NIS elements software BR3.0 (Nikon).
In Vivo Phagocytosis Assay
20 3 106 CFSE-labeled apoptotic cells with or without oxPE (10 mM) were in-
jected i.p. 3 days after induction of peritonitis with thioglycollate. 30 min after
injection of ACs, mice were sacrificed and periteonal lavage was performed as
described above. Cells were washed three times with ice-cold PBS and trans-
ferred into plastic tubes. Antibody staining was performed as indicated for
30 min at 4C and flow cytometry was performed.
Detailed information on phagocytosis assays with the different particles can
be found in the Supplemental Information.
In Vitro OT-II-Proliferation Assay
Macrophage cultures were obtained from peritonitis exudates or resident peri-
toneum as described above. Cells were incubated with either ovalbumin-
transgenic apoptotic cells (MF:AC-ratio 1:5) or soluble ovalbumin (500 mg/ml)
in 96-well plates for 24 hr (100,000 cells/well) in the presence of LPS
(100 ng/ml) with or without oxPE (10 mM). Afterwards, cells were thoroughly
washed five timeswith PBS and incubatedwith enriched (CD4-MACS;Milteny)
CFSE-labeled (CFSE: 5 mM for 5 min at room temperature) OT-II cells for 72 hr
(MF:T cell ratio 1:5). Afterwards, OT-II cells were transferred into plastic tubes
and stained for CD4 and cytofluometry was performed. OT-II proliferation was
measured by CFSE dilution of CD4-positive cells.
In Vivo OT-II-Proliferation Assay
2 days after induction of peritonitis with thioglycollate, 43 106 enriched (CD4-
MACS; Milteny) CFSE-labeled OT-II cells were transferred into wild-type and
Alox15/ mice by intravenous injection. 24 hr later, apoptotic thymocytes
were generated from ovalbumin-transgenic mice (OVAtg) as described above.
203 106 OVAtg ACs were injected intraperitoneally in eachmouse. After 72 hr,
mice were sacrificed, and lymph nodes and spleens were taken. Draining
(mediastinal) lymph nodes were identified by intraperitoneal injection of 10%
indian ink 4 hr before isolation (Figure S2). Single-cell solutions were stained
for CD4 and cytofluometry was performed. OT-II proliferation was measured
by CFSE dilution of CD4-positive cells.
Phospholipid Preparation
The detailed protocol is described in the Supplemental Experimental
Procedures.
Quantification of PE-OH and PE-OOH in Resident Macrophages by
Mass Spectometry
The detailed protocols are described in the Supplemental Experimental
Procedures.
In Vitro MFG-E8-Binding Assay
For the solid-phase ELISA for MFG-E8-binding to phospholipids, 96-well
plates (Nunc MaxiSorp) were coated with 100 ml of solution of PS at a concen-
tration of 3 mg/ml in methanol and air-dried overnight at 4C. The wells were
blocked with 1% BSA in PBS. Indicated oxidized and unoxidized phospho-
lipids were freshly mixed with DMPC at a ratio of 1:8 to create phospholipid
vesicles. Vesicles were added together with recombinant murine MFG-E8
(10 nM; R&D Systems) to the wells and incubated at room temperature for
1 hr. After intense washing with 0.05%-Tween20 in PBS, MFG-E8 bound to
the PS-coated wells was quantified by ELISA with a biotinylated MFG-E8 anti-
body and peroxidase-conjugated streptavidin (R&D Systems). Binding of re-
combinant MFG-E8 to the surface of resident peritoneal macrophages was
performed in 8-well chamber slides and determined by incubating the cells
with MFG-E8 (100 ng/ml) at 4C after fixation with 4% PFA. Bound MFG-E8
was detected by immunofluorescence microscopy, with a biotinylated MFG-
E8 antibody (R&D Systems) and Cy3-labeled streptavidin (Biolegend).
Pristane Model
The detailed protocol is described in the Supplemental Experimental
Procedures.844 Immunity 36, 834–846, May 25, 2012 ª2012 Elsevier Inc.Quantitative Real-Time PCR
The detailed protocols as well as primer sequences are described in the
Supplemental Experimental Procedures.
Statistical Analysis
Data are shown as means ± SD. Group mean values were compared by two-
tailed Student’s t test. The data shown are representative of at least three
experiments producing similar results. ***p < 0.001; **p < 0.01; *p < 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and one table and can be found with this article online at
doi:10.1016/j.immuni.2012.03.010.
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